peptideInjectableNot FDA-approvedResearch chemicalNot approved by the FDA or EMA; clinical use is documented mainly in Russian and Ukrainian gerontology literatureSold in some markets as an unregulated research/compounded peptide outside the US and EU
ThymalinBenefits, Dosage & Interactions
Thymalin is a synthetic polypeptide analogous to thymic factors, primarily derived from calf thymus. It is a peptide with immune-modulating properties and has been a subject of research for its potential role in addressing age-related immune decline. Research on Thymalin focuses on immune function.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Plasma half-life
Not quantified in the cited human sources
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The clinical geroprotective study treated 266 elderly participants with intramuscular Thymalin courses for the first 2–3 years of a 6–8 year observation period; specific per-injection milligram doses were not given in the abstract-level record reviewed[1][3]
Reported for Thymalin in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Thymalin entry is written from. Each number matches an inline marker above.
- [1]Peptides of pineal gland and thymus prolong human lifeKhavinson VKh, Morozov VG · Neuro Endocrinology Letters · 2003 · Peer-reviewed · PMID 14523363
- [2]Thymalin: Activation of Differentiation of Human Hematopoietic Stem CellsKhavinson VK, et al. · Bulletin of Experimental Biology and Medicine · 2020 · Peer-reviewed · PMID 33237528
- [3][Geroprotective effect of thymalin and epithalamin]Khavinson VKh, et al. · Advances in Gerontology · 2002 · Peer-reviewed · PMID 12577695
How to track Thymalin doses
Thymalin is tracked as a protocol rather than a single reminder: a vial with a concentration, a schedule that may be titrated or cycled, and a rotation of injection sites. Here is the record that keeps all three consistent.
- 1
Record the vial and concentration
Log the vial strength and the volume of bacteriostatic water you added so Thymalin is stored as a concentration rather than a guess. DoseRoutine converts that into mg per syringe unit and counts the doses left in the vial as you log.
- 2
Set the schedule, not just a reminder
Enter the dose in mg and the frequency. Cycled protocols get a start and end date so the history stays accurate when Thymalin comes out of the routine.
- 3
Rotate and log the injection site
Pick the site at the moment you log the dose. The site map shows what you used last and how recently, which is the part that drifts fastest when two compounds run on different frequencies.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
Review Thymalin alongside your logged metrics and any relevant blood work every few weeks before changing the dose, so the change is a response to data rather than to a good or bad day.
What to log each time
- Dose in mg and the syringe units it worked out to
- Vial: reconstitution date, concentration, doses remaining
- Injection site and time
- Any side effects in the 24 h after the dose
References & Evidence
Sources on this page that document Thymalin dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Thymalin studied for?
What is Thymalin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Thymalin is a synthetic polypeptide analogous to thymic factors, primarily derived from calf thymus. It is a peptide with immune-modulating properties and has been a subject of research for its potential role in addressing age-related immune decline. In various studies, Thymalin has been investigated for its effects on cellular immunity, including T-cell differentiation and function. It is generally recognized in various scientific literature as an immunomodulator (source: PubChem, DrugBank). Its structure is a short chain of amino acids, which is typical for peptides synthesized for biological activity research. The interest in Thymalin stems from the understanding that the thymus gland plays a crucial role in the development and maturation of T-lymphocytes, which are central to adaptive immunity. As the thymus undergoes age-related atrophy, immune function can decline, making compounds that might support thymic activity or T-cell function of particular research interest. Thymalin's research applications have focused on its potential to support the immune system in various contexts.
What does the research say about Thymalin?
Tap a section to expand.
Thymalin is thought to exert its biological effects primarily through modulation of the immune system, specifically by influencing T-lymphocyte function. Research suggests that it may act on T-cell precursors, promoting their differentiation and maturation into various types of T-cells, including helper T-cells and cytotoxic T-cells (source: scientific review papers). This action is believed to be analogous to the functions of naturally occurring thymic peptides. By potentially supporting the development and activity of these immune cells, Thymalin may enhance the body's ability to mount an effective immune response. Furthermore, evidence suggests that Thymalin might influence the balance of pro-inflammatory and anti-inflammatory cytokines, which are signaling molecules crucial for immune regulation. Some studies indicate that it could help restore immune homeostasis, particularly in conditions associated with immune dysregulation or senescence (source: immunological research articles). It's also hypothesized that Thymalin could play a role in antioxidant defense mechanisms indirectly by improving overall cellular health and reducing oxidative stress, though this area requires further elucidation. The exact molecular targets and downstream signaling pathways of Thymalin are still areas of ongoing research, but current understanding points towards mechanisms that bolster cell-mediated immunity and support overall immune competence.
Source for this section: Sources for How does Thymalin work?: Jumps to this entry in the sources and references list at the end of the page.
Research into Thymalin has explored several potential benefits, primarily centered around its immunomodulatory properties and implications for longevity and recovery. These include:
* **Immune System Support:** A primary area of investigation for Thymalin is its potential to support immune function. Studies, particularly in older populations or those with compromised immunity, have explored its ability to enhance the activity and differentiation of T-lymphocytes. This has led to research into its use in conditions involving immune decline or dysregulation (source: immunological studies, peer-reviewed journals).
* **Anti-Aging Research:** Due to its association with thymic function and T-cell regeneration, Thymalin has been explored in the context of anti-aging. The theory is that by supporting a more robust immune system, particularly one that mimics aspects of youthful immune function, it could contribute to maintaining overall health and resilience as individuals age (source: gerontology research).
* **Recovery Enhancement:** In some investigative settings, Thymalin has been studied for its potential role in aiding recovery processes, particularly after illness or stress that may have impacted immune function. By helping to normalize immune parameters, it might indirectly support the body's natural recovery mechanisms (source: clinical observations, case studies).
* **Cellular Regeneration:** While not a direct regenerative agent in the broader sense, its influence on immune cell development could be interpreted as a form of cellular regeneration within the immune system, potentially contributing to a healthier immune cell population (source: basic science research).
It is important to note that many of these benefits are still under active investigation, and clinical applications are continually being refined based on emerging evidence.
Evidence for Thymalin's effects primarily originates from preclinical studies and clinical investigations conducted in various research centers globally. Much of the early research, particularly concerning its immunomodulatory properties, stems from Eastern European scientific literature. Studies have often focused on its ability to restore aspects of cellular immunity. For instance, observations described in immunological research publications have indicated that Thymalin may influence the count and function of T-lymphocytes, particularly in individuals experiencing immune system challenges or age-related immune decline. These studies, including some human trials, suggest an improvement in several immune parameters, such as increased T-cell subpopulations and enhanced lymphocyte proliferation in response to mitogens (source: various immunology journals, scientific databases). A review of research on peptide bioregulators, including Thymalin, published in specialized journals, has highlighted its potential in supporting immune function, particularly in contexts like recovery from acute illnesses or chronic conditions affecting immunity. While numerous studies support its biological activity and immunomodulatory effects in various models, comprehensive meta-analyses and large-scale, placebo-controlled human trials are continually being sought to solidify the extent and consistency of these benefits across diverse populations and conditions (source: scientific review articles, PubMed-indexed literature). The FDA and EMA have not evaluated Thymalin as a drug in the US or EU, meaning it is not approved for medical use in these regions. The current body of evidence is primarily from research settings exploring its potential physiological impact.
Based on available research and anecdotal reports, Thymalin is generally considered to have a favorable safety profile compared to some more potent immunomodulators. However, as with any biologically active compound, potential side effects can occur.
Reported side effects are typically mild and transient, and comprehensive, large-scale safety trials are still being conducted to fully characterize all potential adverse reactions.
* **Injection Site Reactions:** As Thymalin is administered via injection, common reactions at the injection site may include localized pain, redness, swelling, or discomfort. These reactions are generally mild and self-limiting (source: clinical observations).
* **Allergic Reactions:** Although rare, hypersensitivity reactions are possible with any peptide. Symptoms could include rash, itching, hives, or in severe cases, anaphylaxis. Individuals with known allergies to similar compounds or components should exercise caution (source: general pharmacological principles).
* **Flu-like Symptoms:** Some individuals have reported mild, transient flu-like symptoms such as headache, fatigue, or low-grade fever following administration. These are typically short-lived (source: observational studies).
* **Gastrointestinal Upset:** Uncommonly, some individuals might experience mild gastrointestinal disturbances such as nausea or stomach discomfort (source: anecdotal reports).
It is essential for individuals to discuss any concerns with a healthcare professional before considering the use of Thymalin. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Individuals considering Thymalin should be aware of several warnings related to its use:
* **Immune System Modulation:** As an immunomodulator, Thymalin can influence immune function. Individuals with autoimmune conditions, compromised immune systems, or those taking other immunomodulatory medications should exercise extreme caution and seek medical advice before considering its use. Unsupervised immune modulation could exacerbate existing conditions or interfere with prescribed treatments (source: general immunological principles).
* **Lack of Regulatory Approval:** Thymalin is not approved by regulatory bodies like the FDA in the United States or the EMA in Europe for therapeutic use. This means it has not undergone the rigorous evaluation processes required for prescription medications regarding safety, efficacy, and quality. Its availability is typically in research-grade forms (source: FDA, EMA public information).
* **Unknown Long-Term Effects:** While short-term studies have generally shown a favorable safety profile, robust data on the long-term effects of Thymalin, especially with prolonged administration, are limited. The implications of long-term immune modulation are not fully understood (source: scientific literature gaps).
* **Pregnancy and Breastfeeding:** There is insufficient data regarding the safety of Thymalin during pregnancy or breastfeeding. Therefore, it is generally advised to avoid its use in these populations (source: general medical caution).
* **Pediatric Use:** The safety and efficacy of Thymalin in pediatric populations have not been established. Its use in children is not recommended (source: general medical caution).
* **Sterile Administration:** As an injectable compound, strict sterile techniques must be followed to prevent infection at the injection site (source: standard medical practice).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Thymalin is contraindicated in certain situations where its use could pose significant risks. These contraindications are generally based on scientific principles related to immune modulation and general medical caution, given the compound's mechanism of action and lack of extensive clinical trials.
* **Hypersensitivity:** Individuals with a known allergy or hypersensitivity to Thymalin or any of its excipients should not use this compound. Anaphylactic reactions, though rare, are possible (source: general pharmacological principles).
* **Autoimmune Diseases (Acute Phase):** While some research explores immunomodulators in chronic autoimmune conditions, during acute flares or uncontrolled autoimmune diseases, the use of a compound that modulates immune function could potentially exacerbate the condition. Therefore, it is generally contraindicated without specific medical guidance (source: expert medical consensus, immunological reasoning).
* **Severe Immunodeficiency (Uncontrolled):** In cases of severe or uncontrolled immunodeficiency where the immune system is highly compromised, introducing an immunomodulator without careful medical supervision and diagnosis could be risky (source: general immunological precaution).
* **Organ Transplants (Recent):** Individuals who have undergone organ transplantation and are on immunosuppressive therapy are typically contraindicated given that Thymalin's immunomodulatory effects could interfere with transplant rejection prevention strategies (source: post-transplant medical guidelines).
* **Lymphoproliferative Disorders/Malignancies:** In conditions characterized by uncontrolled proliferation of lymphocytes (e.g., certain leukemias or lymphomas), an immunomodulator like Thymalin, which can influence lymphocyte differentiation and proliferation, might theoretically exacerbate the disease (source: oncological principles, immunological theory).
* **Pregnancy and Lactation:** Due to the absence of sufficient safety data, Thymalin is contraindicated in pregnant and breastfeeding women (source: general medical practice).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Interactions between Thymalin and other medications or supplements have not been extensively studied in large-scale clinical trials. However, given its immunomodulatory properties, caution is advised when combining it with certain classes of compounds:
* **Immunosuppressants:** Co-administration with immunosuppressive medications (e.g., corticosteroids, calcineurin inhibitors, or biologics used in organ transplantation or autoimmune diseases) could theoretically lead to antagonistic effects. Thymalin's potential to boost immune function might counteract the effects of these medications, or conversely, the immunosuppressants might reduce Thymalin's efficacy (source: pharmacological interaction principles).
* **Other Immunomodulators:** Combining Thymalin with other compounds that significantly impact the immune system (e.g., other peptides, herbal immunomodulators, or certain vitamins in very high doses) could result in unpredictable or exaggerated immune effects. Close monitoring and medical supervision would be critical (source: general pharmacological caution).
* **Chemotherapy and Radiation Therapy:** Patients undergoing chemotherapy or radiation therapy, which severely suppress bone marrow and immune function, should not use Thymalin without explicit medical guidance. While some research explores immune support during cancer treatment, unsupervised use could be complex and potentially counterproductive (source: oncology treatment guidelines).
* **Live Vaccines:** Theoretically, concomitant use with live attenuated vaccines could pose a risk, especially if Thymalin significantly enhances certain arms of the immune system, leading to an unpredictable response to the vaccine (source: general vaccinology principles).
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Thymalin is commonly studied in administration protocols that involve regular subcutaneous or intramuscular injections over a specific duration, often for cycles of several days or weeks. Due to its relatively short half-life, more frequent administration might be considered in research settings to maintain consistent levels, though individual needs vary — talk to a licensed clinician. The decision on the best frequency or duration would be user-directed and must be set by a licensed clinician based on specific investigative protocols or individual needs, considering absorption rates and metabolic activity. Meals are generally not considered to significantly interfere with the systemic absorption or efficacy of Thymalin, so it can typically be taken either with or without food. The administration method is often subcutaneous (under the skin) or intramuscular (into the muscle), as is typical for many peptides.
Source for this section: Sources for When should you take Thymalin?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Thymalin?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any peptide + hormone | Note | Category ruleConfidence: theoretical | Injectable peptides plus hormones can have overlapping or compounding effects that aren't always well characterized.Source pending | Track bloodwork with a provider; don't assume combinations are neutral. |
Frequently asked questions about Thymalin
Thymalin is primarily studied for its immunomodulatory properties, specifically its potential to enhance T-lymphocyte function and support the immune system, particularly in contexts of age-related immune decline or compromised immunity. It's also explored in anti-aging research due to these immune-boosting effects (source: PubChem, scientific review papers).
Thymalin is a synthetic polypeptide that is analogous in structure and theoretical function to naturally occurring peptides found in the thymus gland, such as thymalin or thymic factor beta-4, which play roles in immune system development (source: DrugBank, various biomedical research).
Thymalin is typically administered via injection, either subcutaneously (under the skin) or intramuscularly (into the muscle). This is because like many peptides, it would likely be degraded by stomach acids if taken orally (source: general peptide pharmacology).
No, Thymalin is not approved by regulatory agencies like the FDA in the United States or the EMA in Europe for medical use. It is primarily available for research purposes, and its use outside of controlled research is not endorsed by these bodies (source: FDA, EMA official websites).
The main concerns include the lack of extensive human clinical trials to establish long-term safety and efficacy, potential for immune system interactions, and the absence of regulatory approval. Individuals with autoimmune conditions, those on immunosuppressants, or pregnant/breastfeeding individuals should avoid its use (source: scientific literature, general medical caution).
As a peptide, Thymalin can overlap with other supplements, prescription medicines, hormones and peptides. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Thymalin with no sign-up.
Thymalin is administered by injection, so the measured volume — not a tablet count — is the unit that matters. Amounts for this peptide vary by protocol, formulation and individual response, so follow the dose your clinician or the product label specifies.
Whether Thymalin fits alongside testosterone replacement therapy depends on the protocol — dose, ester and ancillaries such as HCG or anastrozole — and on current bloodwork. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
"Peptides" is not one category — healing peptides, GLP-1 agonists, growth-hormone secretagogues and melanocortins each behave differently next to Thymalin. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
Published frequency for Thymalin varies by protocol and formulation, so the label or prescription is what sets it. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
The effect of a missed dose of Thymalin depends on the protocol and formulation you are on. For injectable protocols, shifting the next injection is usually preferred over doubling it. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For an injectable like Thymalin the record needs more than a checkbox: vial concentration, the measured volume, and which site the last injection went into. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Thymalin?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Geroprotective effect of thymalin and epithalamin(opens PubMed in a new tab)Adv Gerontol · 2002 · PMID 12577695 · https://pubmed.ncbi.nlm.nih.gov/12577695/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 3085284(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/3085284
Verify at
Publisher search links for Thymalin. These are places to check the information — they are not citations, so they are not numbered.
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- DailyMed labeling archive(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Thymalin?
Plain-text summary, safe to quote verbatim:
Thymalin is a synthetic polypeptide analogous to thymic factors, primarily derived from calf thymus. It is a peptide with immune-modulating properties and has been a subject of research for its potential role in addressing age-related immune decline. Research on Thymalin focuses on immune function.
Source: DoseRoutine — https://doseroutine.com/library/thymalin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Thymalin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/thymalin
What compounds are similar to Thymalin?
Others in the peptide category or studied for the same goals.
Which goals is Thymalin used for?
Other compounds studied for the same benefits as Thymalin.
Continue exploring
See every compound DoseRoutine catalogs for these goals.